Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
mrp, you do not know the strategic plan ... the Board does ... and it apparently approves of the plan as it has not let TGD go as of today.
They know the process and time line: Board, TGD and the officers/workers of Anavex. It appears no one important is jumping ship.
The plan is in incubation ... let it hatch.
sum, that is right … and I’m not sure Anavex has even filed a draft of it.
Something is cooking … I just don’t know if it is Dreamland ribs or stone soup!!
mike, I noted that last week that the proxy hasn't been filed. It is as if Anavex and TGD were waiting for something to happen ... I assume good since if it were bad, ASM would have been held by now, so the direct questions from shareholders would not have to be answered.
I think good news is coming soon ... even in The Chosen, the word "soon" is always under scrutiny! 😉
Peace, mike,
powerwalker
Thanks, george, for clarifying.
Hosai, check your numerals ... one too many or one too few.
Peace,
powerwalker
sum, when it was formed 5 years ago (ATH, please note, not "7"), Anavex was the principal driver to bring the original group of companies, which is why I've called it the "Anavex Consortium," regardless of the name established.
Obviously, with the new additions over the years, it has a stronger presence and I hope it has greater advancements in its future that will profit mankind ... and, of course, Anavex shareholders.
hnbadgers, the Consortium has added AbbVie, Astellas, Novartis and Neurocrine Biosciences. Sensational adds since the Consortium's start.
P.S. Wish they would all announce a buy of one million Anavex shares each ... including Anavex.
Good Ole Bill, Cognision is a member of the Anavex Consortium that includes Merck, Takeda, Lundbeck and Alkemes along with Sage Therapeutics and Cadent Therapeutics.
https://www.businesswire.com/news/home/20190320005368/en/Industry-Consortium-Launched-to-Qualify-Biomarkers-for-Schizophrenia-Drug-Development
IMO, good news as the Consortium is beginning to move.
mrp, maybe you should answer this?
Rather weak FUD attempt, 2014, as these two companies have been partners for a long time ... as you well know.
Plus, why would Anavex want to partner with Eisai after its partnership with Biogen?
00, you never owned anything ... well, maybe 1 share.
Gary, thanks for your thoughts on today's presentation.
Maybe, it is time to throw away one of those four years of cash and do a stock buy back of 5 million shares at the 2024 high ($6.94). I know that sounds irresponsible, but if you believe that, within three years, approval will be received for one indication (which indicates approval for other applications, too), then the cash will be there for whatever need there is in the future.
It is time to show the market that Anavex has some cojones and that it believes in its pipeline.
Actually, Doc, that is a good one. They know (and might be more worried about) that they can be sued for failure to perform their fiduciary duties, which means their options are worthless, there is no D&O insurance to protect them and they pay out-of-pocket $$$, big ones I might add, for legal defense ... and the friendships turn to hatred (personal experience on that one).
They aren't ready to ditch their friend because ... they know EVERYTHING that we DO NOT!
Blood (Money) is thicker than water (friendship).
Also, if a logic person had read all that the naysayers have written over the last few days and thought those posters were more correct than wrong, then s/he would claim that the BOD is stupid for not firing TGD. This BOD is not stupid ... they know the Anavex plan, 2-73 results and strategy ... and waiting for it to be revealed.
ATH, it is possible the BOD will not "man up" as you think it should because:
1) The members of the Board know the plan and the strategy going forward; you nor anyone on this board knows that.
2) The Board members have seen the full results of all the trials. They agree in principle with 1).
3) They are well aware of TGD's short-comings. His management of 1) and 2) over-rides that concern.
4) Tom Skarpelos is not afraid to pull the plug on a floundering CEO (see Missling's predecessor, Cameron Durrant). He is still in Dr. Missling's corner.
5) Naysayers' success of scaring posters to sell 10K, 50K or 100K over a week's time, is a win for lower prices and its benefactors and indicates a drug's failure. Only, the world's drug agencies will decide a drug's pass or fail. IMO, 2-73 will pass!
Funny, you only show up on beat-down days for this stock, along with several others.
Peace,
powerwalker
Thanks, William. Good to know.
ATH, I have been reading your posts since you came on the board 8-9 years ago. You were never "WGT" as you always had a cautious approach before turning negative.
Rightly or wrongly, I have been a "WGT" member ever since the first trial results of 2-73 were issued in 2015 that showed the "Strong Responders" improved, i.e., reversed their Alzheimer's Disease over the first 31 weeks and all 7 were not using Aricept/DPZ. Continued improvement for them strengthened that faith.
Other results with other diseases have shown 2-73 is better than placebos and current SOC's. So, I stay on the "WGT" side of the opinion line.
Peace,
powerwalker
Here is a status of AD bills in Congress, per my representative:
ATH, you were never WGT!
mrp, I understand what you were going thru last year with a West Point graduation around the same time as the ASM.
However,
Pleassssse!! Anavex numbers were almost 3X better than Acadia's. That we know along with good numbers for the placebo crowd that made p=.067, as opposed to the needed p<.05 that is the sacrosanct number. [If p were linear, a .1 difference in placebo group, might have hit .05.]
Given that, we know nothing else about the Rett trial. There were 77 out of 92 that finished the 2:1 trial and that is all. That is all we know! Most of the dropouts may have been placebo girls as the caretakers did not see any improvements and left the trial, so they could give their charges something, even if it were Acadia's drug.
I would like to think the delay in the ASM is due to waiting on Anavex's and TGD's parts as some newsworthy event might be on the horizon and the ASM is being held up for that. 🤞
But, mrp, on one of these ASM days, I do hope to meet you.
Peace,
powerwalker
So, mrp, when did you go, as last year, you told us you could not attend because of prior and expensive commitments did not allow you to be there? Besides, you did not claim to have attended any previous ones. If you have not attended, how are you able to state, "... a waste of time ..."?
No, I haven't, hnbadger, though I think he is still here under another name. He doesn't post often, but his tone is still the same, as in positive, when he does. He probably lessened his holdings in Anavex after the Rett numbers, but not entirely.
Good morning, bhlloyd. My wife and I attend last year's and met Hoskuld, Bourbon, meds, besides TGD, Clint and the lawyer Parker.
There was no limitation on types of questions or the toughness of them as reported at the time by those MB posters. TGD couched his answers on the tougher questions but did indicate shareholders would be pleased at the numbers for Alzheimer's and Rett.
Mary and I are thinking of attending again (we thought it was worth the trip from NW Indiana), depending when it is held, which was why I asked if anyone had seen a notice about it.
Peace,
powerwalker
Has anyone seen any information on this year's ASM?
Last year, the proxy was issued on April 4th for the May 23rd ASM.
https://www.sec.gov/Archives/edgar/data/1314052/000173112223000573/e4559_def14a.htm
mrp, did he state if it would be a P3 or P4 as Anavex discusses with fda its superior Rett results vs. Acadia's drug (Acadia presents @ Needham later today)?
Has anyone heard of a supplement called "Cognilux"? It makes claims of cleaning waste et al, similar to Anavex, by utilizing certain nutrients.
Did you ask and did he answered any other questions?
Steady, what were your other questions?
plex, that is quite all right. We have all done the same thing ... even mrp, once and a while.
Happy Easter!
plex, it is a draft and has not been approved by the fda. Though it is promising, we won't know until it is finalized and we know how BP is able to flex its muscles, i.e., if we believe it were positive for Anavex, so will BP and it won't like anything positive for Anavex to be adopted by the fda.
Just sayin' ...
Happy Easter to everyone. He is Risen!
mrp, see below re: Annovis statement last week. I would think TGD would want to have data out in the public before Annovis. [Please excuse me if this were posted before now. Underling is my add.]
Thanks, mrp, for that information. From your perspective, it is too bad that wasn't written about management ... but it will be in the end!
"Cheers," is right!! Glad to have you back Tred from your 90 day "sabbatical." Hope you are in good spirits and refreshed.
Very glad you are back.🙂
Thanks, Steady. That is the way I would explain it. If there were value @ $32/share, then the true value must be much higher as these drugs of Anavex are not bolt-on additions, but the real deal directly producing positive results, and possible improvement in the afflicted, in a safe manner.
tschussmann, rate similar to Fidelity. Someone posted awhile back that his/her was in the 12% range.
Thanks for your replies. I don't read all the posts like I did as I'm doing more useful things these days.
Thanks, tschussmann ... we are with Fidelity and it is offering less than 3% last time I looked about 2 weeks ago.
Ziggy, just to keep you current of what some of us know ... other than some option exercising, Anavex did not sell any shares from 9/30/2023 to 2/7/2024 when its Q1 numbers were released. Even after the ped Rett data was released on 1/2/2024, there were no sales thru that February date.
tschussmann, which brokerage firm and what rate are you receiving?
Just for the record on stock sales: Between September 30th (FYE) and February 7 (December 10-Q filed), there were only 54,000 shares issued, which were probably a result of Fadiran's departure. So, for 4+ months, Anavex did not issue any other shares for stock sales.
It will be interesting to see the numbers when March 10-Q is filed in early May.